113 related articles for article (PubMed ID: 22358448)
1. Studies on the biology, histology and cytogenetics of two sublines of a murine ovarian reticular cell sarcoma : Biology of M5 and R16 murine tumor.
Donelli MG; Dolfini E; Catapano C; Finazzi M; Mandelli GC; Volontè M; Fuhrman Conti AM
Cytotechnology; 1987 Oct; 1(1):87-90. PubMed ID: 22358448
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral activity of the oxazaphosphorine derivative, mafosfamide-cyclohexylamine salt (ASTA 7557) on a murine ovarian reticular cell sarcoma and its subline resistant to cyclophosphamide.
Colombo T; Paolini A; Finazzi M; Scanziani E; Mandelli G; Donelli MG
Tumori; 1986 Dec; 72(6):637-42. PubMed ID: 3544404
[TBL] [Abstract][Full Text] [Related]
3. Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
D'Incalci M; Torti L; Damia G; Erba E; Morasca L; Garattini S
Cancer Res; 1983 Dec; 43(12 Pt 1):5674-80. PubMed ID: 6357429
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel mouse reticular cell sarcoma M5076 subline resistant to cisplatin.
Ferrari A; Damia G; Erba E; Rossi C; Mandelli R; D'Incalci M
Int J Cancer; 1989 Jun; 43(6):1091-7. PubMed ID: 2659542
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of 1,4-bis (2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis Maleate) in M5076 and its subline resistant to cyclophosphamide M5/CTX.
Tagliabue G; Filippeschi S; Hendricks H; D'Incalci M
Ann Oncol; 1992 Mar; 3(3):233-6. PubMed ID: 1586622
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin.
Belvedere G; Imperatori L; Damia G; Tagliabue G; Meijer C; de Vries EG; D'Incalci M
Eur J Cancer; 1996 Oct; 32A(11):2011-8. PubMed ID: 8943689
[TBL] [Abstract][Full Text] [Related]
7. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II.
Zhu H; Huang M; Yang F; Chen Y; Miao ZH; Qian XH; Xu YF; Qin YX; Luo HB; Shen X; Geng MY; Cai YJ; Ding J
Mol Cancer Ther; 2007 Feb; 6(2):484-95. PubMed ID: 17308047
[TBL] [Abstract][Full Text] [Related]
8. Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.
Damia G; Tagliabue G; Zucchetti M; Davoli E; Sessa C; Cavalli F; D'Incalci M
Cancer Chemother Pharmacol; 1992; 30(6):459-64. PubMed ID: 1394802
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of a human T-lymphoblastoid cell line.
Snow K; Judd W
Exp Cell Res; 1987 Aug; 171(2):389-403. PubMed ID: 3476309
[TBL] [Abstract][Full Text] [Related]
10. Molecular/cytogenetic alterations accompanying the development of multidrug resistance in the J774.2 murine cell line.
Slovak ML; Lothstein L; Horwitz SB; Trent JM
Leukemia; 1988 Jul; 2(7):453-8. PubMed ID: 2899184
[TBL] [Abstract][Full Text] [Related]
11. Karyotypic derivation of H9 cell line expressing human immunodeficiency virus susceptibility.
Chen TR
J Natl Cancer Inst; 1992 Dec; 84(24):1922-6. PubMed ID: 1460674
[TBL] [Abstract][Full Text] [Related]
12. [The effect of culturing conditions on the karyotypic structure of two cell sublines of Indian muntjak skin fibroblasts].
Polianskaia GG
Tsitologiia; 1989 Jul; 31(7):807-17. PubMed ID: 2815339
[TBL] [Abstract][Full Text] [Related]
13. Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene.
Kovnat A; Buick RN; Choo B; De Harven E; Kopelyan I; Trent JM; Tannock IF
Cancer Res; 1988 Sep; 48(17):4993-5000. PubMed ID: 3409229
[TBL] [Abstract][Full Text] [Related]
14. [The effect of the Mycoplasma contamination of 2 kidney cell sublines from the kangaroo rat on their karyotypic structure].
Polianskaia GG; Efremova TN
Tsitologiia; 1996; 38(1):75-84. PubMed ID: 8768552
[TBL] [Abstract][Full Text] [Related]
15. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
[TBL] [Abstract][Full Text] [Related]
16. Karyotypic evolution of four novel mouse mammary carcinoma cell lines. Identification of marker chromosomes by fluorescence in situ hybridization.
Fabris V; Lamb CA; Keck C; Aldaz CM; Merani S; Lanari C
Cancer Genet Cytogenet; 2003 Apr; 142(1):36-45. PubMed ID: 12660031
[TBL] [Abstract][Full Text] [Related]
17. [Cytogenetic characteristics of the growth of mouse ascitic strain L-5178].
Fomina MM; Minenkova EA; Poroshenko GG; Evseenko LS
Tsitologiia; 1975 Feb; 17(2):188-94. PubMed ID: 1056646
[TBL] [Abstract][Full Text] [Related]
18. Homogeneously staining chromosome regions and double minutes in a mouse adrenocortical tumor cell line.
George DL; Francke U
Cytogenet Cell Genet; 1980; 28(4):217-26. PubMed ID: 6936133
[TBL] [Abstract][Full Text] [Related]
19. In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo.
Okugawa K; Kobayashi H; Hirakawa T; Sonoda T; Ogura T; Nakano H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):178-86. PubMed ID: 14655049
[TBL] [Abstract][Full Text] [Related]
20. Human urinary bladder carcinoma cell line (T24) in long-term culture: chromosomal studies on a wild population and derived sublines.
Malkovský M; Bubeník
Neoplasma; 1977; 24(3):319-26. PubMed ID: 895941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
